Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 |
filingDate |
2008-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101032607-B1 |
titleOfInvention |
Protein marker for diagnosing liver cancer |
abstract |
The present invention is a proteinaceous marker for early diagnosis of liver cancer, liver cancer diagnostic composition comprising a substance for detecting a change in the proteinaceous marker, liver cancer diagnostic kit comprising the liver cancer diagnostic composition, liver cancer diagnostic method using the proteinaceous marker, the protein The present invention relates to a method for screening a liver cancer therapeutic agent using a sex marker, and an antibody that specifically recognizes the proteinaceous marker. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101153935-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101098940-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018208091-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3623814-A4 |
priorityDate |
2008-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |